1.2Hydroxyethyl at the tether position
A two-carbon chain projects from the attachment point and ends in a hydroxyl group. The terminal hydroxyl donates and accepts hydrogen bonds at the exposed end of the chain.
Generated automatically. Not reviewed by a person. Not legal advice or an opinion.
Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
A two-carbon chain projects from the attachment point and ends in a hydroxyl group. The terminal hydroxyl donates and accepts hydrogen bonds at the exposed end of the chain.
Six saturated carbon atoms form the ring, which connects to the core through one ring carbon. The cyclohexyl group adopts a chair conformation and presents a hydrophobic surface.
The ring bonds directly to the carbon of the C≡N group. The linear nitrile provides a permanent dipole and a hydrogen-bond acceptor at its terminal nitrogen.
The linker carbon forms two carbon–fluorine single bonds and retains its two bonds to the surrounding framework. The fluorines withdraw electron density through the single bonds, and the linker carbon has tetrahedral geometry.
The imidazothiazole activates nicotinic acetylcholine receptors on susceptible nematode muscle. Sustained depolarization causes spastic paralysis, allowing intestinal motility to expel the worms.
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Separate granulate batches contain the first anthelmintic and the macrocyclic lactone at fixed active concentrations. A dual-hopper filler dispenses 50 mg of each granulate into the smallest capsule, 100 mg of each into the middle capsule, and 200 mg of each into the largest capsule. The resulting 100 mg, 200 mg, and 400 mg total fill masses preserve the active mass ratio across all three sizes.
A livestock handling station connects an ear-tag reader, a weigh platform, and an oral dispenser with two replaceable cartridges. One cartridge holds the first anthelmintic suspension and the other holds a macrocyclic lactone suspension, each with a dedicated metering pump. A controller matches the tag and measured weight to a stored dosing table, then drives both pumps to deliver their metered volumes through separate channels in a single applicator tip.
A flow-through dissolution apparatus holds the first anthelmintic granulate and the second active granulate in separate cells supplied by a common temperature-controlled medium reservoir. Each cell has its own metered inlet and timed fraction collector, which preserves the release profile of each granulate. Liquid chromatography measures the active concentration in each fraction, and the pressure and flow records identify interruptions during the run.
An at-line near-infrared spectrometer measures each granulate stream before a capsule filler combines the first anthelmintic with the second active. Separate calibration models use chromatographic assay results to relate each granulate spectrum to its active concentration. The filling controller combines the estimated concentrations with the measured fill masses, then diverts capsules when the estimated content of either active falls outside its configured band.
Ra is methyl and Rb is hydrogen. The resulting —NHCH₃ group attaches to the core through nitrogen and retains one nitrogen–hydrogen bond.
One R5 position carries —S(=O)₂CH₃ with p set to 2. The ring connects directly to sulfur, and the two sulfonyl oxygens act as hydrogen-bond acceptors.
R8 is methyl in an N—R8 unit. The nitrogen bonds to the two adjacent framework atoms and to the methyl carbon.
R10 is methoxy, —OCH₃. The oxygen bonds directly to the framework and serves as a hydrogen-bond acceptor.
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
“Cyclic” and “cycloalkyl” refer to a non-aromatic mono- or multicyclic ring system of about 3 to about 10 carbon atoms, e.g., 3, 4, 5, 6, 7, 8, 9, or 10 carbon atoms. The cycloalkyl group can be optionally partially unsaturated.A · US 2007/0232621 A1 · ¶ 126
The aryl group can be optionally substituted (a “substituted aryl”) with one or more aryl group substituents, which can be the same or different, wherein “aryl group substituent” includes alkyl, substituted alkyl, aryl, substituted aryl, aralkyl, hydroxyl, alkoxyl, aryloxyl, aralkyloxyl, carboxyl, acyl, halo, nitro, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, acyloxyl, acylamino, aroylamino, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, arylthio, alkylthio, alkylene, anA · US 2007/0232621 A1 · ¶ 111
R1 is selected from the group of H, OH, Cl, O-Alkyl, NH.sub.2, NH-Alkyl, NH-Ar, N(Alkyl).sub.2, SH, S-Alkyl, S-Ar, S-Hetaryl;B · US 7,557,116 B2 · ¶ 10
wherein: p and q are each independently an integer from 0 to 8; m is an integer from 0 to 4; n is an integer from 0 to 4; each Z, A, and Y is independently selected from the group consisting of N and CR4, wherein R4 is selected from the group consisting of H, hydroxyl, halo, nitro, alkyl, substituted alkyl, alkoxyl, aryl, substituted aryl, and aryloxyl; each R1, R2 and R5 is independently selected from the group consisting of H, hydroxyl, halo, nitro, alkyl, substituted alkylA · US 2007/0232621 A1 · ¶ 88
The aryl group can be optionally substituted (a “substituted aryl”) with one or more aryl group substituents, which can be the same or different, wherein “aryl group substituent” includes alkyl, substituted alkyl, aryl, substituted aryl, aralkyl, hydroxyl, alkoxyl, aryloxyl, aralkyloxyl, carboxyl, acyl, halo, nitro, alkoxycarbonyl, aryloxycarbonyl, aralkoxycarbonyl, acyloxyl, acylamino, aroylamino, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, arylthio, alkylthio, alkylene, anA · US 2007/0232621 A1 · ¶ 111
R2=C6H5 or substituted phenyl: C6H4X′ (where X′=Alkyl, Halogen, NO2, O-Alkyl, N(Alkyl)2, CN, S-Alkyl); or disubstituted; or trisubstituted phenyl;B · US 7,557,116 B2 · claim 1
R2=C6H5 or substituted phenyl: C6H4X′ (where X′=Alkyl, Halogen, NO2, O-Alkyl, N(Alkyl)2, CN, S-Alkyl); or disubstituted; or trisubstituted phenyl;B · US 7,557,116 B2 · claim 1
wherein: p and q are each independently an integer from 0 to 8; m is an integer from 0 to 4; n is an integer from 0 to 4; each Z, A, and Y is independently selected from the group consisting of N and CR4, wherein R4 is selected from the group consisting of H, hydroxyl, halo, nitro, alkyl, substituted alkyl, alkoxyl, aryl, substituted aryl, and aryloxyl; each R1, R2 and R5 is independently selected from the group consisting of H, hydroxyl, halo, nitro, alkyl, substituted alkylA · US 2007/0232621 A1 · ¶ 88
An empty cell means only that no passage was reproduced there.
Thus, there continues to be a need for improvement in the art for additional compounds having desirable antimicrobial activity, whether against the representative pathogens referenced above or against other pathogens.A · US 2007/0232621 A1 · ¶ 60
The presently disclosed subject matter relates to methods for combating microbial infections with novel dicationic terphenyl compounds and their aza analogues, processes for synthesizing novel dicationic terphenyl compounds and their aza analogues, and the novel dicationic terphenyl compounds and their aza analogues themselves.A · US 2007/0232621 A1 · ¶ 2
Derivatives of 5H-pyrano[2,3-d: 6,5-d′]dipyrimidine are the most closely claimed compounds taken as prototypes in the present invention; however, the prototype compounds are shown to possess a limited spectrum of antiviral and antibacterial activity.B · US 7,557,116 B2 · ¶ 7
The derivatives in the present invention, however, posses antibacterial, antiviral and immunomodulating effects.B · US 7,557,116 B2 · ¶ 7
patent.fyi, US 2026/0355190 A1, claim 1, first published 2026-11-19T09:07:06-05:00, https://patent.fyi/US20260355190/, SHA-256 5ce60e56d680294da594e2c2f6e52d0ffe15dce451c514972dfccf6d63920d61